You are here

Coreg

Teva’s generic label not skinny enough to protect from $234M damages to GSK

MedCity News

Sat, 08/7/21 - 11:57 pm

Teva Pharmaceutical

Teva back on the hook for $235M to GSK for heart drug infringement

Fierce Pharma

Mon, 10/5/20 - 11:42 pm

Patent Infringement

'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'

Fierce Pharma

Fri, 09/6/19 - 12:37 pm

Teva Pharmaceutical

Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict

Reuters

Thu, 03/29/18 - 10:01 am

Teva Pharmaceutical

GSK wins $235 million from Teva in Coreg patent trial

Reuters

Fri, 06/23/17 - 09:43 am

Teva Pharmaceutical

chronic heart failure

Glaxo to Pay $750 Million for Sale of Bad Products

NY Times, NY

Wed, 10/27/10 - 09:01 am

drug manufacturing